PUBLISHER: IMARC | PRODUCT CODE: 1541493
PUBLISHER: IMARC | PRODUCT CODE: 1541493
The global pressure ulcers treatment market size reached US$ 5.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.52% during 2024-2032.
Pressure ulcers, also known as bedsores, are degenerative skin and underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They usually affect the bony and muscle areas of the body, such as back, buttocks, tailbone, heels, elbow, shoulder, and ankles. They lead to morbidity and mortality, especially among the masses with impaired sensation, poor nutrition, comorbidities, and prolonged immobility. They are cured by appropriate preventive measures and medications that help prevent deep craters with exposed muscle and bone. Pressure ulcers treatment involves removing necrotic tissue, reducing pressure on the affected skin, caring for wounds, controlling pain, and maintaining good nutrition and a moist environment for wound healing. It also involves wound cleansing with normal saline and appropriate dressings for the infected area. Besides this, early identification and treatment of these ulcers minimize the risk of complications, including bone and joint infections, cellulitis, sepsis, and cancer.
The increasing global geriatric population, which is more susceptible to developing pressure ulcers due to skin fragility and thinning of the cell layers and decreased capillary density and cell growth represents one of the key factors positively influencing the market. In addition, the increasing prevalence of obesity and chronic medical diseases is resulting in the surging occurrence of pressure ulcers. Apart from this, the rising awareness among individuals about the early diagnosis of bedsores, along with the easy availability of treatment, is also contributing to the market growth. Furthermore, the expansion of hospitals, clinics, pharmacies, and drug stores, coupled with the introduction of technological advancements in the healthcare industry, is creating a positive market outlook. Additionally, the rising focus of leading market players on the formulation of novel wound care products is anticipated to drive the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global pressure ulcers treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on ulcer type, product type and end user.
Stage 1
Stage 2
Stage 3
Stage 4
Wound-Care Dressings
Wound-Care Devices
Others
Hospitals
Clinics
Ambulatory Surgical Centers
Homecare Settings
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Molnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation.